Skip to content
Nonprofiteer
← OKLAHOMA HEART HOSPITAL RESEARCH FOUNDATION

Form 990 for tax year 2024

Filed by OKLAHOMA HEART HOSPITAL RESEARCH FOUNDATION.

Totals

Total revenue
$907,178
Total expenses
$1,056,229
Contributions and grants received
$841,380
Grants paid
$0
Program service revenue
$75,552
Investment income
$3,179
Other revenue
-$12,933
Total assets, end of year
$1,278,254
Total liabilities, end of year
$10,454
Net assets or fund balances, end of year
$1,267,800
Program services expenses (Part IX)
$724,148
Management and general expenses
$40,859
Fundraising expenses
$291,222
Program service expenses (Part III)
$724,148

Program services were 68.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $179,962

  • 1f · All other contributions, gifts and grants

    $661,418

  • 1g · Noncash contributions included above

    $5,436

  • 2a · Program service revenue: SCIENTIFIC RESEARCH

    total $75,552 · related or exempt $75,552

  • 3 · Investment income

    total $3,179 · excluded $3,179

  • 6a · Gross rents

    personal property $6,000

  • 6b · Less rental expenses

    personal property $3,803

  • 6c · Rental income or loss

    personal property $2,197

  • 6d · Net rental income or loss

    total $2,197 · unrelated business $2,197

  • 8a · Fundraising events: gross income

    $44,401

  • 8a · Fundraising events: contributions included on line 1c

    $179,962

  • 8b · Fundraising events: direct expenses

    $59,531

  • 8c · Net income from fundraising events

    total -$15,130 · excluded -$15,130

Functional expenses

Part IX, the statement of functional expenses.

  • 5 · Compensation of officers, directors and key employees

    total $314,599 · program services $178,248 · management and general $15,029 · fundraising $121,322

  • 7 · Other salaries and wages

    total $223,436 · program services $175,423 · fundraising $48,013

  • 8 · Pension plan contributions

    total $15,666 · program services $11,142 · management and general $751 · fundraising $3,773

  • 9 · Other employee benefits

    total $83,922 · program services $32,064 · management and general $9,871 · fundraising $41,987

  • 10 · Payroll taxes

    total $44,325 · program services $29,668 · management and general $1,268 · fundraising $13,389

  • 11b · Fees: legal

    total $3,010 · program services $891 · management and general $2,119

  • 11c · Fees: accounting

    total $16,718 · program services $11,899 · management and general $352 · fundraising $4,467

  • 11f · Fees: investment management

    total $242 · management and general $242

  • 11g · Fees: other

    total $71,114 · program services $64,944 · management and general $71 · fundraising $6,099

  • 13 · Office expenses

    total $61,655 · program services $32,354 · management and general $2,412 · fundraising $26,889

  • 14 · Information technology

    total $21,494 · program services $15,520 · management and general $158 · fundraising $5,816

  • 16 · Occupancy

    total $123,339 · program services $112,896 · management and general $4,332 · fundraising $6,111

  • 17 · Travel

    total $1,413 · program services $1,148 · management and general $24 · fundraising $241

  • 22 · Depreciation, depletion and amortization

    total $9,152 · program services $8,759 · fundraising $393

  • 23 · Insurance

    total $30,943 · program services $23,615 · management and general $2,528 · fundraising $4,800

  • 24a · Other expenses: FEDERAL INCOME TAX ON U

    total $252 · management and general $252

  • 24b · Other expenses: PATIENT PAYMENTS AND SU

    total $14,464 · program services $14,464

  • 24c · Other expenses: PROFESSIONAL DEVELOPMEN

    total $6,061 · program services $6,061

  • 24d · Other expenses: BANK AND CREDIT CARD FE

    total $3,894 · management and general $1,118 · fundraising $2,776

  • 24e · All other expenses

    total $10,530 · program services $5,052 · management and general $332 · fundraising $5,146

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $114,809 · end of year $128,466

  • 2 · Savings and temporary cash investments

    beginning of year $227,422 · end of year $248,210

  • 4 · Accounts receivable

    beginning of year $839,889 · end of year $670,456

  • 9 · Prepaid expenses and deferred charges

    beginning of year $10,823 · end of year $11,360

  • 10a · Land, buildings and equipment: cost or other basis

    $299,802

  • 10b · Land, buildings and equipment: accumulated depreciation

    $173,188

  • 10c · Land, buildings and equipment, net

    beginning of year $137,801 · end of year $126,614

  • 11 · Investments: publicly traded securities

    beginning of year $37,978 · end of year $41,466

  • 12 · Investments: other securities

    beginning of year $25,000 · end of year $25,000

  • 14 · Intangible assets

    beginning of year $3,341 · end of year $1,432

  • 15 · Other assets

    beginning of year $25,250 · end of year $25,250

  • 17 · Accounts payable and accrued expenses

    beginning of year $7,943 · end of year $10,454

  • 29 · Capital stock, trust principal or current funds

    beginning of year $0 · end of year $0

  • 30 · Paid-in or capital surplus, or land, building or equipment fund

    beginning of year $0 · end of year $0

  • 31 · Retained earnings, endowment or other funds

    beginning of year $1,414,370 · end of year $1,267,800

Mission and programs · 2024

Mission

CONDUCT NONPROFIT CLINICAL RESEARCH FOR TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS.

Activities or mission (Part I)

CONDUCT NONPROFIT CLINICAL RESEARCH FOR TREATMENT OF CARDIOVASCULAR DISEASE.

  • ADVANCE QUALITY PATIENT CARE IN TREATMENT OF CARDIOVASCULAR DISORDERS AND OTHER MEDICAL DISEASES BY PERFORMING NON-PROFIT MEDICAL CLINICAL RESEARCH AND INVESTIGATION OF MEDICAL DRUG AND DEVICE TECHNOLOGY.

    Expenses $436,352 · Revenue $75,552

  • FACILITATE MEDICALLY NEEDY PATIENTS WITH FREE MEDICAL THERAPY OR TREATMENT AT SUBSTANTIALLY REDUCED OR NO COSTS. FACILITATE HOSPITAL TREATMENT FOR PATIENTS WITH NO MEDICAL INSURANCE OR WHO ARE SIGNIFICANTLY UNDERINSURED.

    Expenses $285,912

  • PARTICIPATE IN CLINICAL RESEARCH STUDIES PERFORMED BY THE NATIONAL INSTITUTE OF HEALTH, THE NATIONAL INSTITUTE OF HEART LUNG AND BLOOD, AND VARIOUS UNIVERSITIES INCLUDING OKLAHOMA HEALTH SCIENCES CENTER, DUKE UNIVERSITY AND GEORGE WASHINGTON.INITIATE INDEPENDENT SCIENTIFIC RESEARCH RELATED TO TREATMENT OF CARDIAC DISORDERS AND OTHER MEDICAL DISEASES.

  • EDUCATE GENERAL PUBLIC AND MEDICAL COMMUNITY ABOUT HEART DISIEASE & RISK FACTORS OF CARDIAC DISEASE. PROMOTE AWARENESS OF DRUG AND MEDICAL DEVICE TECHNOLOGY AMONG PHYSICIANS AND THE PUBLIC.

    Expenses $1,884

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Thomas Hennebry MD

    PRESIDENT/MEDICAL DIRECTOR

    Total calculated
    $0
    Hours/week
    10

  • Marvin Woodall

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Mohammad Ghani MD

    SECRETARY/DIRECTOR

    Total calculated
    $0
    Hours/week
    5

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Schedule J

Answered yes

  • 3 · Written employment contract
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • OKLAHOMA CARDIOVASULAR RESEARCH GROUP INC

    C · FOR PROFIT CLINICAL TESTING · OK · 100% owned · controlled entity

Provenance

Return type
form_990
Tax year
2024
Filed
14 November 2025
IRS schema version
2024v5.2
Source object
202533189349304498

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.